Perspective Therapeutics, Inc.

The current price of CATX is 1.58 USD — it has decreased by 1.25% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Perspective Therapeutics, Inc. stocks are traded under the ticker CATX.

Perspective Therapeutics, Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.

CATX stock is 5.81% volatile and has beta coefficient of −0.08. Check out the list of the most volatile stocks — is Perspective Therapeutics, Inc. there?

CATX earnings for the last quarter are −0.04 USD per share, whereas the estimation was −0.05 USD resulting in a 11.11% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about Perspective Therapeutics, Inc. earnings.

Perspective Therapeutics, Inc. revenue for the last quarter amounts to ‪1.91 M‬ USD despite the estimated figure of ‪1.85 M‬ USD. In the next quarter revenue is expected to reach ‪1.80 M‬ USD.

Yes, you can track Perspective Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

CATX stock has risen by 9.72% compared to the previous week, the month change is a 26.40% rise, over the last year Perspective Therapeutics, Inc. has showed a 187.17% increase.

Today Perspective Therapeutics, Inc. has the market capitalization of ‪939.07 M‬, it has increased by 4.79% over the last week.

No, CATX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, CATX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Perspective Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

CATX reached its all-time high on Feb 11, 1988 with the price of 243.75 USD, and its all-time low was 0.003 USD and was reached on Apr 8, 2004.
See other stocks reaching their highest and lowest prices.

As of Apr 27, 2024, the company has 119.00 employees. See our rating of the largest employees — is Perspective Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Perspective Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Perspective Therapeutics, Inc. stock shows the strong buy signal. See more of Perspective Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Perspective Therapeutics, Inc. future price: according to them, CATX price has a max estimate of 2.00 USD and a min estimate of 1.50 USD. Read a more detailed Perspective Therapeutics, Inc. forecast: see what analysts think of Perspective Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Perspective Therapeutics, Inc. EBITDA is ‪−29.83 M‬ USD, and current EBITDA margin is ‪−2.78 K‬%. See more stats in Perspective Therapeutics, Inc. financial statements.